OverviewChartNewsTraderScreen

L&S Knock-Out EVT 12.06.2024/  DE000LX3WQ96  /

Lang & Schwarz
2024-06-01  1:03:52 PM Chg.-0.001 Bid1:03:52 PM Ask1:03:52 PM Underlying Strike price Expiration date Option type
0.078EUR -1.27% 0.078
Bid Size: -		 0.098
Ask Size: -		 EVOTEC SE INH O.N. 8.00 EUR 2024-06-12 Call
GlobeNewswire 05-14 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 2023-12-11 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 2023-11-07 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 2020-08-20 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 2019-02-07 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2019-02-07 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2018-02-15 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 2018-01-08 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 2017-09-14 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 2011-11-29 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 2011-11-10 Evotec reports nine months results: Upside materialising
GlobeNewswire 2011-11-03 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 2011-10-27 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 2011-10-20 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 2011-10-05 Evotec announces second multi-target collaboration with UCB
GlobeNewswire 2011-09-29 Evotec acquires remaining 30% of Indian Joint Venture from DIL
GlobeNewswire 2011-09-09 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 2011-09-05 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire 2011-09-05 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire 2011-08-18 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire 2011-08-11 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire 2011-08-11 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire 2011-08-04 Evotec to Report Second Quarter 2011 Results on 11 August 2011
GlobeNewswire 2011-07-07 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire 2011-06-30 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...